Prenat-CI50 mg+0.5 mg+61.8 mg

Prenat-CI is a combination hematinic and micronutrient supplement used for the prevention and treatment of iron-deficiency anemia and associated folate and zinc deficiency.

Established/Well-Supported Uses

• Treatment of iron-deficiency anemia, including anemia due to inadequate dietary iron intake, chronic blood loss, or increased physiological demand.
• Prevention and treatment of iron, folate, and zinc deficiency during pregnancy and lactation, consistent with WHO antenatal micronutrient supplementation guidance.
• Nutritional supplementation during periods of rapid growth (infancy, childhood, adolescence) when dietary intake is inadequate, under medical supervision.

Adjunct/Supportive Uses

• As an adjunct to correct micronutrient deficiency during convalescence, malabsorption states, or restrictive diets, alongside treatment of the underlying cause.

Prenat-CI does not treat anemia caused by conditions other than iron, folate, or zinc deficiency (e.g., vitamin B12 deficiency, thalassemia, chronic disease anemia); a physician should confirm the underlying cause before starting therapy.

Each unit of Carbonyl Iron + Folic Acid + Zinc Sulfate Monohydrate typically contains carbonyl iron (an elemental, purified iron powder) equivalent to a specified amount of elemental iron, together with folic acid and zinc sulfate monohydrate (providing elemental zinc). Exact strengths vary by manufacturer and formulation (tablet, capsule, or syrup); refer to the product label for the precise composition of Carbonyl Iron + Folic Acid + Zinc Sulfate Monohydrate being dispensed.

Prenat-CI is an oral combination product formulated to correct iron-deficiency anemia along with concurrent folic acid and zinc deficiency. Carbonyl iron is a highly purified, elemental form of iron that is absorbed more slowly and in a more controlled manner than ionic iron salts (such as ferrous sulfate or ferrous fumarate), which is associated with a comparatively favorable gastrointestinal tolerability profile and a wider safety margin in accidental overdose. Folic acid supports red blood cell production and is essential during pregnancy for fetal neural tube development. Zinc sulfate monohydrate supplies elemental zinc, a trace mineral required for immune function, growth, and wound healing. Together, the components of Prenat-CI are used to prevent and treat combined iron, folate, and zinc deficiency, particularly in pregnancy, childhood growth, and recovery from illness.

Prenat-CI belongs to the therapeutic class of hematinics (anti-anemia preparations) and nutritional/micronutrient supplements, combining an elemental iron source, a B-vitamin (folic acid), and a trace mineral (zinc).

Carbonyl iron (in Carbonyl Iron + Folic Acid + Zinc Sulfate Monohydrate) is elemental iron that must first be oxidized and dissolved in gastric acid before absorption in the duodenum and proximal jejunum, the same general route used by dietary iron. Its slower dissolution compared with ionic iron salts leads to more gradual, controlled absorption, replenishing hemoglobin synthesis in erythroid precursor cells while reducing peak free-iron exposure in the gut.

Folic acid (in Carbonyl Iron + Folic Acid + Zinc Sulfate Monohydrate) is a synthetic form of vitamin B9 that is reduced to tetrahydrofolate, a cofactor required for one-carbon transfer reactions in DNA synthesis and red blood cell maturation; it corrects megaloblastic changes and supports the increased erythropoiesis needed during iron repletion.

Zinc sulfate monohydrate (in Carbonyl Iron + Folic Acid + Zinc Sulfate Monohydrate) provides elemental zinc, absorbed mainly in the small intestine, which functions as a cofactor for numerous metalloenzymes involved in immune function, protein synthesis, cell division, and wound healing.

Prenat-CI is taken by mouth, preferably with water. It may be taken on an empty stomach for optimal absorption, but may be taken with food if it causes stomach upset, since carbonyl iron is generally better tolerated than ionic iron salts. Swallow tablets/capsules whole; do not crush or chew unless the product is specifically designed to be chewed. Avoid taking with tea, coffee, or calcium-rich dairy products, which can reduce iron absorption; separate dosing from these by at least 1-2 hours where possible.

Prenat-CI can interact with certain medications through reduced absorption or altered efficacy:

• Tetracyclines and fluoroquinolone antibiotics: Iron chelates with these antibiotics, reducing absorption of both. Separate administration by at least 2-3 hours.
• Levothyroxine: Iron can reduce levothyroxine absorption; separate dosing by at least 4 hours.
• Calcium-containing products and antacids: May reduce iron and zinc absorption; avoid co-administration.
• Penicillamine: Zinc may reduce absorption of penicillamine; separate dosing.
• Additional iron or zinc supplements: Concomitant use of separate iron or zinc supplements beyond Prenat-CI should be avoided without medical guidance, as excessive intake of one mineral can impair absorption of the other and increase toxicity risk.

The most common side effects associated with Prenat-CI relate to the gastrointestinal tract and include nausea, stomach cramps, constipation or diarrhea, and dark or black-colored stools (a harmless effect of iron). Carbonyl iron's controlled-release absorption is generally associated with better gastrointestinal tolerability than ionic iron salts. Zinc, especially on an empty stomach, may occasionally cause additional nausea or a metallic taste. Rarely, allergic reactions (rash, itching, swelling) may occur.

Prenat-CI is commonly used during pregnancy and lactation to correct iron, folate, and zinc deficiency, and folic acid supplementation is specifically recommended to reduce the risk of neural tube defects. However, as with any supplement, Prenat-CI should be used during pregnancy and breastfeeding only if clearly needed and at doses recommended by a physician; the potential benefit should justify any potential risk. Consult a physician before use, particularly to confirm dosing and avoid inadvertent excess iron or zinc intake.

Use Prenat-CI with caution in individuals with a history of gastrointestinal disorders (e.g., peptic ulcer disease, inflammatory bowel disease), as iron and zinc can aggravate GI symptoms. Excess supplemental zinc beyond what is provided in Prenat-CI should be avoided, as it can interfere with iron and copper absorption and, with prolonged high intake, cause copper deficiency. Iron overdose remains a serious and potentially fatal risk in young children even with carbonyl iron's improved safety margin; keep Prenat-CI in a childproof container out of the reach of children at all times. Prenat-CI should not replace medical evaluation of the underlying cause of anemia; if there is no improvement despite adherence, or symptoms worsen, consult a physician. See Contraindications and Interaction for additional safety information.

Although carbonyl iron carries a wider margin of safety than ionic iron salts in accidental overdose, taking substantially more than the prescribed dose of Prenat-CI can still cause toxicity, particularly in children, with symptoms such as nausea, vomiting, abdominal pain, diarrhea, or lethargy. Excess zinc can cause additional gastrointestinal symptoms. In case of suspected overdose, seek immediate medical attention or contact a poison control center/emergency services right away; do not attempt home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Renal impairment: No specific dose adjustment is generally required for Prenat-CI, but iron and zinc supplementation should be guided by a physician, especially in patients on dialysis with altered iron metabolism.

Hepatic impairment: Use Prenat-CI with caution; iron overload can worsen certain liver conditions (e.g., hemochromatosis-related liver disease); see Contraindications.

Elderly: No specific dose adjustment is generally required; monitor for gastrointestinal tolerability.

See Pediatric Uses for information on use of Prenat-CI in children.

Treatment with Prenat-CI for iron-deficiency anemia is typically continued for 3 to 6 months, or for about 3 months after hemoglobin normalizes, to replenish iron stores, as advised by a physician. For prophylactic use during pregnancy, Prenat-CI is generally continued throughout pregnancy and, if advised, during lactation. Duration should be individualized based on follow-up blood test results.

Carbonyl Iron + Folic Acid + Zinc Sulfate Monohydrate is classified as a hematinic (antianemic preparation) and multi-micronutrient nutritional supplement, combining an elemental iron source, a folate (vitamin B9) source, and a zinc source.

The components of Carbonyl Iron + Folic Acid + Zinc Sulfate Monohydrate act together to correct iron-deficiency anemia and associated micronutrient deficiency: carbonyl iron is oxidized in the stomach and absorbed as ferrous iron in the small intestine to replenish hemoglobin and iron stores; folic acid is converted to its active tetrahydrofolate form to support DNA synthesis and red cell maturation; and zinc, absorbed in the small intestine, serves as an essential cofactor for enzymes involved in cellular metabolism, immune function, and growth.

Use of Prenat-CI in children should be guided by a pediatrician, with weight-based or age-appropriate dosing to correct diagnosed iron, folate, or zinc deficiency or to support growth when dietary intake is inadequate. Safety and efficacy of this specific fixed-dose combination have not been formally established across all pediatric age groups; formal pediatric dosing recommendations exist for the individual components (iron, folic acid, and zinc) rather than for this combination product specifically. Prenat-CI must be stored safely out of children's reach, since accidental ingestion of iron-containing products is a recognized cause of serious pediatric poisoning.